Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study. [electronic resource]
Producer: 20161013Description: 545-50 p. digitalISSN:- 1600-0609
- Adult
- Aged
- Benzoates -- administration & dosage
- Biomarkers
- Deferasirox
- Erythrocyte Indices
- Female
- Hemochromatosis -- complications
- Hemochromatosis Protein
- Histocompatibility Antigens Class I -- genetics
- Humans
- Iron Chelating Agents -- administration & dosage
- Iron Overload -- diagnosis
- Male
- Membrane Proteins -- genetics
- Middle Aged
- Mutation
- Time Factors
- Treatment Outcome
- Triazoles -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.